CUBE vs HROW · P/E 25, rev $1.07B vs rev $199.6M
CubeSmart (CUBE) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported HROW revenue for 2024-12-31 was $199.6M. Net income was -$17.5M. Revenue was up 53.3% from 2023-12-31 to 2024-12-31. HROW currently screens at market cap $1.28B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. HROW currently screens at market cap $1.28B.
Not investment advice. Open the CUBE and HROW stock pages for the full models.
Not investment advice.